Secondary stroke prevention in people with atrial fibrillation: treatments and trials
Authors:
Top Cited Papers
Open Access
- 18 March 2024
- journal article
- review article
- Published by Elsevier in The Lancet Neurology
- Vol. 23 (4) , 404-417
Abstract
No abstract availableKeywords
Funding Information
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
This publication has 119 references indexed in Scilit:
- Association Between Intracerebral Hemorrhage and Subsequent Arterial Ischemic Events in Participants From 4 Population-Based Cohort StudiesJAMA Neurology, 2021
- Assessment of Catheter Ablation or Antiarrhythmic Drugs for First-line Therapy of Atrial FibrillationJAMA Cardiology, 2021
- Direct oral anticoagulants versus vitamin K antagonists after recent ischemic stroke in patients with atrial fibrillationAnnals of Neurology, 2019
- Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial FibrillationJAMA, 2019
- Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial FibrillationJAMA, 2019
- Prestroke and Poststroke Antithrombotic Therapy in Patients With Atrial FibrillationJAMA Network Open, 2018
- Oral Anticoagulation and Functional Outcome after Intracerebral HemorrhageAnnals of Neurology, 2017
- Association of Preceding Antithrombotic Treatment With Acute Ischemic Stroke Severity and In-Hospital Outcomes Among Patients With Atrial FibrillationJAMA, 2017
- Anticoagulant Reversal, Blood Pressure Levels, and Anticoagulant Resumption in Patients With Anticoagulation-Related Intracerebral HemorrhageJAMA, 2015
- Percutaneous Left Atrial Appendage Closure vs Warfarin for Atrial FibrillationJAMA, 2014